A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2004
10/28/2004	WO2004091612A1 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes
10/28/2004	WO2004091611A1 Carbonic anhydrase inhibitors to eradicate helicobacter pylori
10/28/2004	WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	WO2004091609A2 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
10/28/2004	WO2004091608A1 Decreasing the incidence of atrial fibrillation (af) in patients with left ventricular dysfunction with ace inhibitors or angiotensin ii receptor antagonists
10/28/2004	WO2004091606A1 Treatment of bronchial asthma using 5-ht3 receptor antagonists
10/28/2004	WO2004091605A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
10/28/2004	WO2004091603A1 Use of an ester of dha for the treatment of cardiovascular diseases
10/28/2004	WO2004091602A1 Use of l-carnitine for the treatment of cardiovascular diseases
10/28/2004	WO2004091601A1 Floating oral formulations for controlled release of betaine
10/28/2004	WO2004091600A1 Solid preparation for oral use
10/28/2004	WO2004091599A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol
10/28/2004	WO2004091598A1 Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
10/28/2004	WO2004091597A2 Method of treating irritable bowel syndrome (ibs)
10/28/2004	WO2004091596A2 Combination therapies for chronic obstructive pulmonary disease (copd)
10/28/2004	WO2004091595A1 Use of alkyl resorcinols in the treatment of acne
10/28/2004	WO2004091594A1 Use of geraniol in antitumoral therapy
10/28/2004	WO2004091593A2 Methods for the treatment of pain comprising opioid antagonists
10/28/2004	WO2004091592A2 Methods and compositions to treat myocardial conditions
10/28/2004	WO2004091591A2 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
10/28/2004	WO2004091589A1 Transdermally administerable tranquilizing and sedating agent
10/28/2004	WO2004091588A1 Pharmaceutical composition containing levodopa and carbidopa
10/28/2004	WO2004091587A1 Multiple release anti-diabetic drugs and process of production thereof
10/28/2004	WO2004091583A1 Chrono delivery formulations and method of treating atrial fibrillation
10/28/2004	WO2004091582A1 Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
10/28/2004	WO2004091580A1 Venlafaxine compositions comprising pellets with double layer coating
10/28/2004	WO2004091578A2 Novel encochleation methods, cochleates and methods of use
10/28/2004	WO2004091576A1 Formulations and methods for treating rhinosinusitis
10/28/2004	WO2004091575A1 Nasal pharmaceutical formulations and methods of using the same
10/28/2004	WO2004091574A1 Nasal pharmaceutical formulations and methods of using the same
10/28/2004	WO2004091572A2 Cochleate compositions directed against expression of proteins
10/28/2004	WO2004091553A2 Film forming polymers, methods of use, and devices and applications thereof
10/28/2004	WO2004091547A2 Compounds, compositions, and methods
10/28/2004	WO2004091546A2 Central nervous system stimulant and opioid antagonist combinations
10/28/2004	WO2004091545A2 Selectively inhibiting estrogen production and providing estrogenic effects in the human body
10/28/2004	WO2004091542A2 Nitrogen containing integrin targeting compounds
10/28/2004	WO2004091541A2 Methods for the controlled delivery of pharmacologically active compounds
10/28/2004	WO2004091540A2 Methods of treating pain and compositions for use therefor
10/28/2004	WO2004091539A2 Fluid mixing methods and apparatus
10/28/2004	WO2004091538A2 Homogeneous, thermoreversible alginate films and soft capsules made therefrom
10/28/2004	WO2004091537A2 Process for making gel films
10/28/2004	WO2004091536A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/28/2004	WO2004091535A2 Methods of administering estrogens and progestins
10/28/2004	WO2004091533A2 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
10/28/2004	WO2004091532A2 Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
10/28/2004	WO2004091531A2 Methods and devices for epithelial protection during photodynamic therapy
10/28/2004	WO2004091530A2 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
10/28/2004	WO2004091529A2 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
10/28/2004	WO2004091528A2 Delivery systems of homogeneous thermoreversible alginate films
10/28/2004	WO2004091527A2 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films
10/28/2004	WO2004091522A2 Method for treating neurodegenerative disorders
10/28/2004	WO2004091521A2 Methods and compositions for administration of trpv1 agonists
10/28/2004	WO2004091519A2 Methods of preventing or treating respiratory conditions
10/28/2004	WO2004091516A2 Methods for controlling the proliferation of cells
10/28/2004	WO2004091514A2 Cgrp receptor antagonists
10/28/2004	WO2004091513A2 9-aminomethyl substituted minocycline compounds
10/28/2004	WO2004091512A2 Abuse-resistant oral dosage forms and method of use thereof
10/28/2004	WO2004091506A2 Taxane-based compositions and methods of use
10/28/2004	WO2004091504A2 Substituted quinobenzoxazine analogs
10/28/2004	WO2004091502A2 1,2,4-oxadiazole benzoic acid compounds
10/28/2004	WO2004091497A2 Methods and compositions for increasing the anaerobic working capacity in tissues
10/28/2004	WO2004091496A2 Lysophosphatidic acid analogs and inhibition of neointima formation
10/28/2004	WO2004091494A2 Method for preparation of site-specific protein conjugates
10/28/2004	WO2004091492A2 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
10/28/2004	WO2004091489A2 Topical blood pressure composition
10/28/2004	WO2004091488A2 Estrogen receptor modulators
10/28/2004	WO2004091486A2 Compounds for the treatment of metabolic disorders
10/28/2004	WO2004091485A2 Aminoquinoline compounds
10/28/2004	WO2004091484A2 Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en22-one 16-0-(2-0-4-methoxybenzoyl-beta-d-xylopyranosyl)-(1->3)-(2-0acetyl-alpha-l-arabinopyranoside)] or osw-1 and its derivatives for cancer therapeutics
10/28/2004	WO2004091483A2 Once daily formulations of tetracyclines
10/28/2004	WO2004091482A2 M3 muscarinic acetylcholine receptor antagonists
10/28/2004	WO2004091474A2 Methods for the preparation of dhea derivatives
10/28/2004	WO2004091436A2 Methods and compositions for treating ocular disease
10/28/2004	WO2004091280A2 Pharmaceutical compositions
10/28/2004	WO2004091278A2 Gabapentin compositions
10/28/2004	WO2004085345A3 15α-SUBSTITUTED ESTRADIOL CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS
10/28/2004	WO2004084769A3 Stents
10/28/2004	WO2004082583A3 Use of oligogalacturonides in cosmetics or for the preparation of a dermatological or pharmaceutical composition
10/28/2004	WO2004082581A3 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
10/28/2004	WO2004080461A3 Stable pharmaceutical compositions of desloratadine
10/28/2004	WO2004080444A3 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using cav2.2 subunit calcium channel modulators
10/28/2004	WO2004080422A3 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
10/28/2004	WO2004080379A3 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect
10/28/2004	WO2004078166A3 Use of omega-3-fatty acids in the treatment of diabetic patients
10/28/2004	WO2004078111A3 Extended release minocycline compositions and processes for their preparation
10/28/2004	WO2004078105A3 Fondaparinux sodium composition of high purity, method for production of said composition and pharmaceutical compositions containing the same as active ingredient
10/28/2004	WO2004078104A3 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy
10/28/2004	WO2004075828A3 Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
10/28/2004	WO2004073612A3 Estrogen receptor modulators
10/28/2004	WO2004072085A3 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
10/28/2004	WO2004072030A3 Process for preparing pyrrolotriazine kinase inhibitors
10/28/2004	WO2004071442A3 Novel bicyclic compounds and compositions
10/28/2004	WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004	WO2004069167A3 Method and compositions for treating male infertility
10/28/2004	WO2004067093A3 Nk1 receptor antagonists for the treatment of functional dyspepsia
10/28/2004	WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders
10/28/2004	WO2004062577A3 Two or more enteric materials to regulate drug release
10/28/2004	WO2004058791A3 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/28/2004	WO2004058721A3 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
10/28/2004	WO2004058170A3 Methods for treating malaria by modulation of g protein function

1 ... 4909 4910 4911 4912 4913 4914 4915 4916 4917 4918 4919 4920 4921 4922 4923 4924 4925 4926 4927 4928 4929 ... 7860